Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about HCA Healthcare, Inc.
HCA Healthcare, Inc. News
HCA Healthcare, Inc. Quantitative Score
About HCA Healthcare, Inc.
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
HCA Healthcare, Inc. Earnings & Revenue
HCA Healthcare, Inc. Financials
Table Compare
Compare HCA metrics with: | |||
---|---|---|---|
Earnings & Growth | HCA | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | HCA | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | HCA | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | HCA | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
HCA Healthcare, Inc. Income
HCA Healthcare, Inc. Balance Sheet
HCA Healthcare, Inc. Cash Flow
HCA Healthcare, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
Metrics | Score |
---|---|
Discounted Cash Flows | Neutral |
Return on Equity | Strong Sell |
Return on Assets | Strong Buy |
Debt/Equity Ratio | Strong Sell |
Price/Earnings Ratio | Sell |
Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
HCA Healthcare, Inc. Dividends
Yield (TTM) | Dividend (TTM) | |
---|---|---|
Infinity% | 2.5800 |
Payment Date | Dividend | Frequency |
---|---|---|
2024-09-30 | 0.66 | Quarterly |
2024-06-28 | 0.66 | Quarterly |
2024-03-29 | 0.66 | Quarterly |
2023-12-28 | 0.6 | Quarterly |
2023-09-29 | 0.6 | Quarterly |
HCA Healthcare, Inc. Valuation
Project future cash flows and get the intrinsic value per share.
Historical Market Cap
Shares Outstanding
HCA Healthcare, Inc. Executives
Name | Role |
---|---|
Mr. Samuel N. Hazen | Chief Executive Officer & Director |
Mr. Jon Mack Foster | Executive Vice President & Chief Operating Officer |
Mr. Michael R. McAlevey | Executive Vice President and Chief Legal & Administrative Officer |
Mr. Timothy M. McManus | President of National Group |
Mr. Erol R. Akdamar FACHE | President of American Group |
Name | Role | Gender | Date of Birth | Pay |
---|---|---|---|---|
Mr. Samuel N. Hazen | Chief Executive Officer & Director | Male | 1960 | 7.12M |
Mr. Jon Mack Foster | Executive Vice President & Chief Operating Officer | Male | 1962 | 3.58M |
Mr. Michael R. McAlevey | Executive Vice President and Chief Legal & Administrative Officer | Male | 1964 | 2.7M |
Mr. Timothy M. McManus | President of National Group | Male | 1972 | 2.66M |
Mr. Erol R. Akdamar FACHE | President of American Group | Male | 1967 | 2.48M |
HCA Healthcare, Inc. Insider Trades
Date | 10 Sep |
Name | Cuffe Michael S. |
Role | EVP and Chief Clinical Officer |
Transaction | Acquired |
Type | M-Exempt |
Shares | 22080 |
Date | 10 Sep |
Name | Cuffe Michael S. |
Role | EVP and Chief Clinical Officer |
Transaction | Disposed |
Type | F-InKind |
Shares | 13722 |
Date | 12 Sep |
Name | Cuffe Michael S. |
Role | EVP and Chief Clinical Officer |
Transaction | Disposed |
Type | S-Sale |
Shares | 8358 |
Date | 10 Sep |
Name | Cuffe Michael S. |
Role | EVP and Chief Clinical Officer |
Transaction | Disposed |
Type | M-Exempt |
Shares | 22080 |
Date | 8 Aug |
Name | Marks Mike A |
Role | EVP and CFO |
Transaction | Disposed |
Type | G-Gift |
Shares | 2237 |
Date | Name | Role | Transaction | Type | Shares |
---|---|---|---|---|---|
10 Sep | Cuffe Michael S. | EVP and Chief Clinical Officer | Acquired | M-Exempt | 22080 |
10 Sep | Cuffe Michael S. | EVP and Chief Clinical Officer | Disposed | F-InKind | 13722 |
12 Sep | Cuffe Michael S. | EVP and Chief Clinical Officer | Disposed | S-Sale | 8358 |
10 Sep | Cuffe Michael S. | EVP and Chief Clinical Officer | Disposed | M-Exempt | 22080 |
8 Aug | Marks Mike A | EVP and CFO | Disposed | G-Gift | 2237 |